Treatment of Paraphilic Sexual Disorders

Handbook of Sexual and Gender Identity Disorders

Volumn , Issue , 2012, Pages 563-586

  Fedoroff, J Paul ^a  

^a ROYAL OTTAWA HEALTH CARE GROUP   (Canada)

Author keywords

Atypical sexual behaviors; Mood disorders; Paraphilic sexual disorders; Sex offenders; Surgical treatments

Indexed keywords

EID: 84886338012     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118269978.ch18     Document Type: Chapter

References (106)

1. Abel, G. G., Blanchard, E. B., & Jackson, M. (1974). The role of fantasy in the treatment of sexual deviation. Archives of General Psychiatry, 30, 467-475.
2. Abel, G. G., Osborn, C., Anthony, D., & Gardos, P. (1992). Current treatments of paraphiliacs. In J. Bancroft, C. M. Davis, & H. J. Ruppel (Eds.), Annual review of sex research: An integrative and interdisciplinary review (Vol. 3, pp. 255-290). Allentown, PA: Society for the Scientific Study of Sex.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4. Appelt, M., & Floru, L. (1974). Erfahmigen uberdie beemflussung der sexualital cyproteronacetat. International Pharmaco-Psychiatry, 9, 61-76.
5. Balon, R. (2000). Lithium for paraphilias? Probably not. Journal of Sex and Marital Therapy, 26, 361-363.
6. Bandura, A. (1978). Social learning theory of aggression. Journal of Communication, 28, 12-29.
7. Bandura, A., & Walters, R. H. (1974). Catharsis: A questionable mode of coping with violence. In S. K. Steinmetz & M. A. Straus (Eds.), Violence in the family (pp. 303-307). New York: Dodd, Mead.
8. Berlin, F. S. (1997). "Chemical castration" for sex offenders. New England Journal of Medicine, 336(14), 1030.
9. Berlin, F. S. (2005). Commentary: The impact of surgical castration on sexual recidivism risk among civilly committed sexual offenders. Journal of the American Academy of Psychiatry and the Law, 33(1), 37-41.
10. Bianchi, M. D. (1990). Fluoxetine treatment of exhibitionism. American Journal of Psychiatry, 147(8), 1089-1090.
11. Bradford, J. (1997). Medical interventions in sexual deviance. In D. R. Laws & W. O'Donohue (Eds.), Sexual deviance: Theory, assessment, and treatment (pp. 449-464). New York: Guilford Press.
12. Bradford, J. M. W. (1996). The role of serotonin in the future of forensic psychiatry. Bulletin of the American Academy of Psychiatry and the Law, 24(1), 57-72.
13. Bradford, J. M. W. (2000). The treatment of sexual deviation using a pharmacological approach. Journal of Sex Research, 37(3), 248-257.
14. Bradford, J. M. W., & Fedoroff, J. P. (2006). Pharmacologic treatment of the juvenile offender. In H. E. Barbaree & W. L. Marshall (Eds.), The juvenile sex offender (2nd ed., pp. 358-382). New York: Guilford Press.
15. Bradford, J. M. W., & Greenberg, D. M. (1996). Pharmacological treatment of deviant sexual behavior. Annual Review of Sex Research, 7, 283-306.
16. Bradford, J. M. W., & Pawlak, A. (1993). Doubleblind placebo crossover study of cyproterone acetate in the treatment of the paraphilias. Archives of Sexual Behavior, 22(5), 383-402.
17. Brown, W. A., Monti, P. M., & Corriveau, D. P. (1978). Serum testosterone and sexual activity and interest in men. Archives of Sexual Behavior, 7(2), 97-103.
18. Cesnik, J. A., & Coleman, E. (1989). Use of lithium carbonate in the treatment of autoerotic asphyxia. American Journal of Psychotherapy, 43(2), 277-286.
19. Chubner, B. A., Ryan, D. P., Luiz, P.-A., Garcia-Carbonero, R., & Calabresi, P. (2001). Antineoplastic agents. In J. G. Hardman, L. E. Limbird, & A. G. Gilman (Eds.), The pharmacologic basis of therapeutics (10th ed., pp. 1389-1459). New York: McGraw-Hill.
20. Coleman, E., Cesnick, J., Moore, A., & Dwyer, S. N. (1992). An exploratory study of the role of psychotropic medications in the treatment of sex offenders. Journal of Offender Rehabilitation, 18, 75-88.
21. Cooper, A. J., & Cernovsky, Z. Z. (1994). Comparison of cyproterone acetate (CPA) and leuprolide acetate (LHRH agonist) in a chronic pedophile: A clinical case study. Biological Psychiatry, 36, 269-271.
22. Cooper, A. J., Cernovsky, Z., & Magnus, R. V. (1992). The long-term use of cyproterone acetate in pedophilia: A case study. Journal of Sex and Marital Therapy, 18, 292-302.
23. Cooper, A. J., Sandhu, S., Losztyn, S., & Cernovsky, Z. (1992). A double-blind placebo controlled trial of medroxyprogesternone acetate and cyproterone acetate with seven pedophiles. Canadian Journal of Psychiatry, 37, 6687-6693.
24. Cornu, F. (1973). Katamnesen bei kkastrierten. In F. Cornu (Ed.), Katamnesen bei kkastrierten (pp. 1-132). Verlag für Medizin und Naturwissenschaften, Basel, Switzerland: S. Karger, AG.
25. Cremonocini, C., Viginati, E., & Libroia, A. (1976). Treatment of hirsuitism and acne in women with two combinations of cyproterone acetate and thinyloestradiol. Acta Europa Fertility, 7, 299-314.
26. Dickey, R. (1992). The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist. Canadian Journal of Psychiatry, 37, 567-569.
27. Ellis, A. (1984). The essence of RET. Journal of Rational-Emotive Therapy, 2, 19-25.
28. Emmanuel, N. P., Lydiard, R. B., & Ballenger, J. C. (1991). Fluoxetine treatment of voyeurism. American Journal of Psychiatry, 148(7), 950.
29. Fagan, P. J. (2004). Sexual disorders: Perspectives on diagnosis and treatment. Baltimore: Johns Hopkins University Press.
30. Fedoroff, J. P. (1988). Buspirone hydrochloride in the treatment of transvestic fetishism. Journal of Clinical Psychiatry, 49(10), 408-409.
31. Fedoroff, J. P. (1989). Buspirone and transvestitic fetishism. Journal of Clinical Psychiatry, 50, 361.
32. Fedoroff, J. P. (1992). Buspirone hydrochloride in the treatment of an atypical paraphilia. Archives of Sexual Behavior, 21(4), 401-406.
33. Fedoroff, J. P. (1993). Serotonergic drug treatment of deviant sexual interests. Annals of Sex Research, 6, 105-121.
34. Fedoroff, J. P. (2003). The paraphilic world. In S. B. Levine, C. B. Risen, & S. E. Althof (Eds.), Handbook of clinical sexuality for mental health professionals (pp. 333-356). New York: Brunner-Routledge.
35. Fedoroff, J. P., & Fedoroff, I. C. (1992). Buspirone and paraphilic sexual behavior. Journal of Offender Rehabilitation, 18(3/4), 89-108.
36. Fedoroff, J. P., & Moran, B. (1997). Myths and misconceptions about sex offenders. Canadian Journal of Human Sexuality, 6(4), 263-276.
37. Fedoroff, J. P., Peyser, C., Franz, M. L., & Folstein, S. E. (1994). Sexual disorders in Huntington's disease. Journal of Neuropsychiatry, 6(2), 147-153.
38. Fedoroff, J. P., Smolewska, K., Selhi, Z., Ng, E., & Bradford, J. M. W. (2001). Victimless pedophiles. Paper presented at the International Academy of Sex Research Twenty-seventh annual meeting, Montreal, Quebec, Canada.
39. Freund, K. (1980). Therapeutic sex drive reduction. Acta Psychiatrica Scandinavica, 62, 3-38.
40. Gaensbauer, T. J. (1973). Castration in treatment of sex offenders: An appraisal. Rocky Mountain Medical Journal, 70, 23-28.
41. Greenberg, D. M., Bradford, J. M. W., Curry, S., & O'Rourke, A. (1996). A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: A retrospective study. Bulletin of the American Academy of Psychiatry and the Law, 24(4), 525-532.
42. Grossman, L. S., Martis, B., & Fichtner, C. G. (1999). Are sex offenders treatable? A research overview. Psychiatric Services, 50(3), 349-361.
43. Habermann, N., Kafka, M. P., Berger, W., & Hill, A. (2006). The paraphilia-related disorders: An investigation of the relevance of the concept in sexual murderers. Journal of Forensic Sciences, 51, 683-688.
44. Hanson, R. K., & Bussière, M. T. (1998). Predicting relapse: A meta-analysis of sexual offender recidivism studies. Journal of Consulting and Clinical Psychology, 66(2), 348-362.
45. Hanson, R. K., Gordon, A., Harris, A. J. R., Marques, J. K., Murphy, W., Quinsey, V. L., et al. (2002). First report of the collaborative outcome data project on the effectiveness of psychological treatment for sex offenders. Sexual Abuse: A Journal of Research and Treatment, 14(2), 169-194.
46. Hanson, R. K., & Harris, A. (2000). The sex offender need assessment rating (SONAR): A method for measuring change in risk levels. In Corrections Research: Manuals and Forms (pp. 1-23). Ottawa, Ontario, Canada: Department of the Solicitor General of Canada.
47. Heim, N. (1981). Sexual behavior of castrated sex offenders. Archives of Sexual Behavior, 10(1), 11-19.
48. Heim, N., & Hursch, C. J. (1979). Castration for sex offenders: Treatment or punishment? A review and critique of recent European literature. Archives of Sexual Behavior, 8(3), 281-304.
49. Hicks, P. K. (1993). Castration of sexual offenders. Journal of Legal Medicine, 14, 641-667.
50. Hucker, S., Langevin, R., & Bain, J. (1988). A double-blind trial of sex drive reducing medication in pedophiles. Annals of Sex Research, 1(2), 227-242.
51. Judd, L. L., Paulus, M. J., Schettler, P. J., Akiskal, H. S., Endicott, J., Leon, A. C., et al. (2000). Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? American Journal of Psychiatry, 157, 1501-1504.
52. Kafka, M. P. (1991a). Successful antidepressant treatment of nonparaphilic sexual addictions and paraphilias in men. Journal of Clinical Psychiatry, 52(2), 60-65.
53. Kafka, M. P. (1991b). Successful treatment of paraphilic coercive disorder (a rapist) with fluoxetine hydrochoride. British Journal of Psychiatry, 158, 844-847.
54. Kafka, M. P. (1994). Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: An open trial. Annals of Clinical Psychiatry, 6, 189-195.
55. Kafka, M. P., & Coleman, E. (1991). Serotonin and paraphilias: The convergence of mood, impulse, and compulsive disorders. Journal of Clinical Psychopharmacology, 11(3), 223-224.
56. Kafka, M. P., & Hennen, J. (2000). Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia-related disorders: A case series. Journal of Clinical Psychiatry, 61(9), 664-670.
57. Kafka, M. P., & Prentky, R. A. (1998). Attentiondeficit/ hyperactivity disorder in males with paraphilias and paraphilia-related disorders: A comorbidity study. Journal of Clinical Psychiatry, 59(7), 388-396.
58. Kerbeshian, J., & Burd, L. (1991). Tourette's syndrome and recurrent paraphilic masturbatory fantasy. Canadian Journal of Psychiatry, 36(2), 155-157.
59. Kilmann, P. R., Sabalis, R. F., Gearing, I. M. L., Bukstel, L. H., & Scovern, A. W. (1982). The treatment of sexual paraphilias: A review of the outcome research. Journal of Sex Research, 18(3), 193-252.
60. Kruesi, M. J. P., Fine, S., Valladares, L., Phillips, R. A., & Rapoport, J. L. (1992). Paraphilias: A double-blind crossover comparison of clomipramine versus desipramine. Archives of Sexual Behavior, 21(6), 587-593.
61. Lalumiere, M. L., Harris, G. T., Quinsey, V. L., & Rice, E. J. (2005). The causes of rape: Understanding the differences in male propensity for sexual aggression. Washington, DC: American Psychological Association.
62. Laschet, U., & Laschet, L. (1971). Psychopharmacotherapy of sex offenders with cyproterone acetate. Pharmakopsychiatrie Neuropsychopharmakologic, 4, 99-104.
63. Laschet, U., & Laschet, L. (1975). Antiandrogens in the treatment of sexual deviations of men. Journal of Steroid Biochemistry, 6, 821-826.
64. Laws, D. R. (1995). Verbal satiation: Notes on procedure, with speculations on its mechanism of effect. Sexual Abuse: A Journal of Research and Treatment, 7(2), 155-166.
65. Laws, D. R. (2001). Olfactory aversion: Notes on procedure, with speculations on its mechanism of effect. Sexual Abuse: Journal of Research and Treatment, 13(4), 275-287.
66. Laws, D. R., & Marshall, W. L. (1991). Masturbatory reconditioning with sexual deviates: An evaluative review. Advances in Behavior Research and Therapy, 13, 13-25.
67. Laws, D. R., & O'Donohue, W. (Eds.). (1997). Sexual deviance: Theory, assessment, and treatment. New York/London: Guilford Press.
68. Laws, D. R., & O'Neil, J. A. (1981). Variations on masturbatory reconditioning. Behavioral Psychotherapy, 9, 111-136.
69. Lorefice, L. S. (1991). Fluoxetine treatment of a fetish. Journal of Clinical Psychiatry, 52(1), 41.
70. Marks, I., Gelder, M., & Bancroft, J. (1970). Sexual deviants two years after electric aversion. British Journal of Psychiatry, 117, 173-185.
71. Marques, J. K., Day, D. M., Nelson, C., & West, M. A. (1994). Effects of cognitive-behavioral treatment on sex offender recidivism. Criminal Justice and Behavior, 21(1), 28-54.
72. Marques, J. K., Wiederanders, M., Day, D. M., Nelson, C., & Van Ommeren, A. (2005). Effects of a relapse prevention program on sexual recidivism: Final results from California's Sex Offender Treatment and Evaluation Project (SOTEP). Sexual Abuse: A Journal of Research and Treatment, 17(1), 79-107.
73. Marquis, J. (1970). Orgasmic reconditioning: Changing sexual object choice through controlling masturbation fantasies. Journal of Behavior Therapy and Experimental Psychiatry, 1, 263-271.
74. Marshall, D. S., & Suggs, R. C. (1971). Human sexual behavior. In D. S. Marshall & R. C. Suggs (Eds.), Human sexual behavior (pp. 3-294). New York: Basic Books.
75. Marshall, W. L. (1973). The modification of sexual fantasies: A combined treatment approach to the reduction of deviant sexual arousal. Behavior Research and Therapy, 11, 557-564.
76. Marshall, W. L. (1979). Satiation therapy: A procedure for reducing deviant sexual arousal. Journal of Applied Behavior Analysis, 12, 10-22.
77. Marshall, W. L., Fernandez, Y. M., Hudson, S. M., & Ward, T. (Eds.). (1998). Sourcebook of treatment programs for sexual offenders. New York and London: Plenum Press.
78. Marshall, W. L., Marshall, L. E., Serran, G. A., & Fernandez, Y. M. (2006). Treating sexual offenders: An integrated approach. New York: Routledge.
79. Maurice, W. L. (2005). Male hypoactive sexual disorder. In R. Balon & R. T. Segraves (Eds.), Handbook of sexual dysfunction (pp. 67-109). Boca Ratan, FL: CRC Press.
80. McConaghy, N., Armstrong, M. S., & Blaszczynski, A. (1985). Expectancy, covert sensitization and imaginal desensitization in compulsive sexuality. Acta Psychiatrica Scandinavica, 72, 176-187.
81. McConaghy, N., Blaszczynski, A., & Kidson, W. (1988). Treatment of sex offenders with imaginal desensitization and/or medroxyprogesterone. Acta Psychiatrica Scandinavica, 77, 199-206.
82. McHugh, P. R., & Slavney, P. R. (1983). The perspectives of psychiatry. In P. R. McHugh & P. R. Slavney (Eds.), The perspectives of psychiatry (2nd ed., pp. 1-332). Baltimore, MD: Johns Hopkins University Press.
83. Nagayama Hall, G. C. (1995). Sexual offender recidivism revisited: A meta-analysis of recent treatment studies. Journal of Consulting and Clinical Psychology, 63(5), 802-809.
84. Neumann, F., & Kalmus, J. (1991). Cyproterone acetate in the treatment of sexual disorders. Pharmacological Base and Clinical Experience, 98(2), 71-80.
85. Ortmann, J. (1980). The treatment of sexual offenders. International Journal of Law and Psychiatry, 3, 443-451.
86. Pearson, H. J., Marshall, W. L., Barbaree, H. E., & Southmayd, S. (1992). Treatment of a compulsive paraphiliac with buspirone. Annals of Sex Research, 5(4), 239-246.
87. Perilstein, R. D., Lipper, S., & Friedman, L. J. (1991). Three cases of paraphilias responsive to Fluoxetine treatment. Journal of Clinical Psychiatry, 52(4), 169-170.
88. Pfaus, J. G., Kippin, T. E., & Centeno, S. (2001). Conditioning and sexual behavior: A review. Hormones and Behavior, 40, 1-31.
89. Pithers, W. D., Marques, J. K., Gibat, C. C., & Marlatt, G. A. (1983). Relapse prevention with sexual aggressives: A self-control model of treatment and maintenance of change. In J. G. Greer & I. R. Stuart (Eds.), The sexual aggressor: Current perspectives on treatment (pp. 214-239). New York: Van Nostrand Reinhart.
90. Roesler, A., & Witztum, E. (1995). Successful treatment of paraphilic sex offenders with long acting GnRH analog triptorelin (decapeptyl-CR). Hormone Research, 82.
91. Rousseau, L., Couture, M., Dupont, A., Labrie, F., & Couture, N. (1990). Effect of combined androgen blockade with and LHRH agonist and flutamide in one severe case of male exhibitionism. Canadian Journal of Psychiatry, 35, 338-341.
92. Sausville, E., & Longo, D. L. (2001). Principles of cancer treatment. In E. Braunwald, S. L. Hauser, A. S. Fauci, D. L. Longo, D. L. Kasper & J. L. Jameson (Eds.), Harrison's principles of internal medicine (15th ed., pp. 543-544). New York: McGraw-Hill.
93. Serber, M. (1970). Shame aversion therapy. Journal of Behavior Therapy and Experimental Psychiatry, 1, 213-215.
94. Shotly, M., Ephross, P. H., Plaut, S. M., Fischman, S., H., Charnas, J. F., & Cody, C. A. (1984). Female orgasmic experience: A subjective study. Archives of Sexual Behavior, 13, 155-164.
95. Southren, A. L., Gorodon, G. G., Vitteck, J., & Altman, K. (1977). Effects of progestagens on androgen metabolism. In L. Martini & M. Motta (Eds.), Androgens and antiandrogens (pp. 263-279). New York: Raven Press.
96. Stein, D. J., Hollander, E., Anthony, D. T., Schneier, F. R., Fallon, B. A., Liebowitz, M. R., et al. (1992). Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias. Journal of Clinical Psychiatry, 53(8), 267-271.
97. Sturup, G. K. (1968). Treatment of sexual offenders in Herstedvester, Denmark. Acta Psychiatrica Scandinavica, 44, 1-64.
98. Sturup, G. K. (1972). Castration: The total treatment. In H. L. P. Resnik & M. E. Wolfgang (Eds.), Treatment of the sex offender (Vol. 8, pp. 175-196). Boston: Little, Brown.
99. Sulloway, F. J. (1983). Freud, biologist of the mind. New York: Basic Books.
100. Thibaut, F., Cordier, B., & Kuhn, J.-M. (1993). Effect of a long-lasting gonadotrophin hormonereleasing hormone agonist in six cases of severe male paraphilia. Acta Psychiatrica Scandinavica, 87, 445-450.
101. Thibaut, F., Cordier, B., & Kuhn, J.-M. (1996). Gonadotrophin hormone releasing hormone agonist in cases of severe paraphilia: A lifetime treatment? Psychoneuroendocrinology, 21(4), 411-419.
102. VanDeventer, A. D., & Laws, D. R. (1978). Orgasmic reconditioning to redirect sexual arousal in pedophiles. Behavior Therapy, 1978, 748-765.
103. Waldinger, M. D. (2005). Male ejaculation and orgasmic disorders. In R. Balon & R. T. Segraves (Eds.), Handbook of sexual dysfunction (pp. 215-248). Boca Raton, FL: CRC Press.
104. Ward, T., Hudson, S. M., & Keenan, T. (1998). A self-regulation model of the sexual offense process. Sexual Abuse: A Journal of Research and Treatment, 10(2), 141-157.
105. Wille, R., & Beier, K. M. (1989). Castration in Germany. Annals of Sex Research, 2, 103-133.
106. Zohar, J., Kaplan, Z., & Benjamin, J. (1994). Compulsive exhibitionism successfully treated with fluvoxamine: A controlled case study. Journal of Clinical Psychiatry, 55(3), 86-88.